Neutrogena is owned by Kenvue (the United States, NYSE: KVUE), which was separated from Johnson & Johnson on 23 August 2023.[1][2] Before Kenvue, Neutrogena was owned by Johnson & Johnson from 1994 to 2023.[2]
Neutrogena began in 1930 with a transparent glycerine soap made in Belgium and imported to the United States, sold on the claim that it rinsed completely and left no residue. It grew into a mass dermatological skin care range, was acquired by Johnson & Johnson in 1994, and moved to Kenvue in 2023.
Kimberly-Clark agreed to acquire Kenvue in a cash and stock transaction that would combine Huggies and Kleenex with Tylenol, Listerine and Neutrogena. The deal is subject to shareholder and regulatory approvals.
Johnson & Johnson separated its consumer health business as Kenvue, which listed in May 2023 and was fully split off through an exchange offer completed on 23 August 2023. Tylenol, Band-Aid, Listerine, Neutrogena and Johnson's Baby all moved to the new company.